SCHEMBL17803692

SCHEMBL17803692

c1ccc(C(CNc2ncnc3ccccc23)c2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 5/20 0.62
▸ NR2F2 P24468 4/20 0.62
▸ GALR3 O60755 3/20 0.62
▸ RAB9A P51151 3/20 0.62
▸ SMN1; SMN2 Q16637 6/20 0.60
▸ HTT P42858 5/20 0.60
▸ LMNA P02545 4/20 0.60
▸ MAPK1 P28482 2/20 0.60
▸ TSHR P16473 1/20 0.60
▸ APP P05067 2/20 0.59
▸ LDHA P00338 1/20 0.57
▸ GAA P10253 3/20 0.56
▸ MAPT P10636 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ DAPK3 O43293 1/20 0.54
▸ MAP4K4 O95819 1/20 0.54
▸ ABL1 P00519 1/20 0.54
▸ ERBB2 P04626 1/20 0.54
▸ PIM1 P11309 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17803682 0.93 EGFR (0.55) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17803701 0.86 NR2F2 (0.62) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17803686 0.84 NR2F2 (0.59) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL16259077 0.82 EGFR (0.59) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17803687 0.82 SLC6A3 (0.56) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17803690 0.79 SLC6A3 (0.52) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL8549176 0.78 RPS6KB1 (0.52) AURKBNPC1
SCHEMBL17800017 0.78 RAB9A (0.48) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17800016 0.78 RAB9A (0.48) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL11249827 0.77 GBA1 (0.57) EGFRNR2F2GALR3RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3226867-A1 HETEROCYCLIC COMPOUNDS AS BIOGENIC AMINE TRANSPORT MODULATORS Ananthan, Subramaniam (US) 2017-10-11 — — EP disclosed
WO-2016090296-A1 HETEROCYCLIC COMPOUNDS AS BIOGENIC AMINE TRANSPORT MODULATORS ANANTHAN SUBRAMANIAM (US) 2016-06-09 — — WO disclosed
Send feedback